Acorda Therapeutics Cdt buy melinda
Start price
13.09.18
/
50%
€85.24
Target price
01.10.18
€151.54
Performance (%)
25.02%
End price
01.10.18
€106.56
Summary
This prediction ended on 01.10.18 with a price of €106.56. The prediction had a final performance of 25.02%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Acorda Therapeutics Cdt | - | - | - | - |
| iShares Core DAX® | 1.051% | -1.833% | 12.822% | 15.392% |
| iShares Nasdaq 100 | -0.547% | -3.738% | 40.625% | 42.396% |
| iShares Nikkei 225® | -1.778% | -8.115% | 16.092% | 0.891% |
| iShares S&P 500 | 0.002% | -2.226% | 28.387% | 41.095% |
Comments by melinda for this prediction
In the thread Acorda Therapeutics Cdt diskutieren
SecteurRecherche biotechnologique et médicale Agenda 01/11 Publication de résultats
Develops and markets therapeutic products for nervous system disorders
Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders.
Its two main products are Ampyra and Zanaflex Capsules.
The Ampyra is an oral drug, which treats to improve walking in patients with multiple sclerosis and Zanaflex Capsules, which is a short acting drug for the management of spasticity, a symptom of many central nervous system disorders, including multiple sclerosis and spinal cord injury.
The company was founded by Ronald Cohen in 1995 and is headquartered in Ardsley, NY.
Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders.
Its two main products are Ampyra and Zanaflex Capsules.
The Ampyra is an oral drug, which treats to improve walking in patients with multiple sclerosis and Zanaflex Capsules, which is a short acting drug for the management of spasticity, a symptom of many central nervous system disorders, including multiple sclerosis and spinal cord injury.
The company was founded by Ronald Cohen in 1995 and is headquartered in Ardsley, NY.
Nombre d'employés : 484 personnes.
(Vom Mitglied beendet)
Stopped prediction by melinda for Acorda Therapeutics Cdt
Acorda Therapeutics Cdt
Start price
Target price
Perf. (%)
€0.61
06.05.23
06.05.23
€0.60
06.05.24
06.05.24
-22.31%
06.06.23
06.06.23
Acorda Therapeutics Cdt
Start price
Target price
Perf. (%)
€4.14
14.03.20
14.03.20
€9.00
04.11.21
04.11.21
-17.87%
05.11.21
05.11.21
Acorda Therapeutics Cdt
Start price
Target price
Perf. (%)
€10.86
02.11.19
02.11.19
€15.00
14.03.20
14.03.20
-61.88%
14.03.20
14.03.20
Acorda Therapeutics Cdt
Start price
Target price
Perf. (%)
€71.11
24.02.19
24.02.19
€83.89
04.03.19
04.03.19
13.09%
04.03.19
04.03.19
Acorda Therapeutics Cdt
Start price
Target price
Perf. (%)
€119.10
02.07.17
02.07.17
€129.60
24.08.17
24.08.17
13.60%
24.08.17
24.08.17
Acorda Therapeutics Cdt
Start price
Target price
Perf. (%)
€107.43
02.07.17
02.07.17
€116.90
24.08.17
24.08.17
13.60%
24.08.17
24.08.17
Acorda Therapeutics Cdt
Start price
Target price
Perf. (%)
€92.41
06.04.17
06.04.17
€151.54
28.06.17
28.06.17
13.62%
28.06.17
28.06.17
Acorda Therapeutics Cdt
Start price
Target price
Perf. (%)
€137.43
04.11.13
04.11.13
€150.00
05.05.14
05.05.14
4.79%
05.05.14
05.05.14
Acorda Therapeutics Cdt
Start price
Target price
Perf. (%)
€119.16
13.11.10
13.11.10
€138.00
13.05.11
13.05.11
-12.69%
13.05.11
13.05.11